-
-
-
-
-
-
-
Akebia Therapeutics (AKBA) Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
-
-
-
-
-
-
-
Akebia Therapeutics Appoints Myles Wolf, M.D., M.M.Sc., Chief of Nephrology and Professor at Duke University School of Medicine, to Board of Directors
-
-
-
-
-
-
-
Akebia Therapeutics Announces Preliminary Full-Year 2018 Financial Results and Business Highlights
-
-
-
-
-
-
-
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
-
-
-
-
-
-
-
Akebia Therapeutics Appoints Cynthia Smith to Its Board of Directors
-
-
-
-
-
-
-
Axial Biotherapeutics Expands Board of Directors with Appointments of Independent Members Ronald C. Renaud Jr. and Henry C. (“Hank”) Wolf
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/14 (CTRP) (PERY) (SHAK) Higher; (PBYI) (DGLY) (KSS) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

